NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients

Not Yet RecruitingPhase 2, Phase 3

Sponsor: Ain Shams University

Conditions: Rheumatoid Arthritis (RA), Manegmentof Rheumatoid Arthritis

Interventions: Ginkgo Biloba Extract (120 mg ) manufuctured by EMA PHARM

this study aims to measure The Effect of Gingko Biloba on the Clinical Outcome of Rheumatoid Arthritis Patients ,the outcomes are hsCRp,calprotectin,DAS-28,HAQ-DI

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:1. Adult patients (older than 18 years) 2. With moderate to high disease activity defined as DAS-28 score ≥ 3.2 3. Patients receiving stable regimen of one or more csDMARDs for the past 6 months

\-

Exclusion Criteria:

\- 1. Patients with known hypersensitivity to Ginkgo biloba 2. Patients receiving Ginkgo biloba for any other indications 3. Patients on biologic DMARDs 4. Patients with impaired liver functions (liver transaminases level ≥ three times upper normal limits), impaired kidney functions (estimated glomerular filtration rate (eGFR) \< 30 ml/min), 5. Patients with any of the following comorbidities: congestive heart failure, history of myocardial infarction, severe anemia, active infections, other inflammatory diseases, and malignancies.

6\. Patients with other autoimmune diseases